Merck, known as MSD outside of the United States and Canada, announced positive topline results from the phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback